BPA for firsdapse
Active Awarded Last action
- Contract number
- 36E79726A0018
- Awardee
-
Catalyst Pharmaceuticals, Inc. UEI J1B2ARLKWN53
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 27% complete
- IDV ceiling
- $15,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center established a Blanket Purchase Agreement with Catalyst Pharmaceuticals, Inc. on July 17, 2026, against the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a ceiling of $15.5 million and an ultimate completion date of July 16, 2027.
The BPA procures FDA-approved rare disease therapies, predominantly Firdapse (amifampridine) 10mg tablets, for delivery to the Department of Veterans Affairs. Performance is conducted at Catalyst's Bartlett, Tennessee facility. The GSA Pharmaceuticals and Drugs Schedule parent vehicle, awarded June 1, 2026, carries a $105.895 million ceiling and extends through May 31, 2031, providing the contracting framework for this BPA and associated delivery orders.
Recent ordering activity under the parent GSA Schedule includes delivery orders from Veterans Integrated Service Network 5 for Firdapse 10mg tablets and from VISN 20 for bulk pharmaceutical supplies, with individual orders ranging from approximately $19.5 thousand to $203 thousand. Delivery order frequency has increased in 2026 following a decline through 2025, with the recent establishment of the GSA Schedule contract supporting a shift toward larger, more stable ordering patterns.
Quick answers
Who was awarded contract 36E79726A0018?
36E79726A0018 was awarded to Catalyst Pharmaceuticals, Inc. by National Acquisition Center (Headquarters) on July 17, 2026.
How much is contract 36E79726A0018 worth?
36E79726A0018's own ceiling is $15,500,000.
Who can order from contract 36E79726A0018?
36E79726A0018 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79726A0018 under another contract?
Yes. 36E79726A0018 is a blanket purchase agreement under 36F79726D0132, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79726A0018 competed?
The extent of competition for 36E79726A0018 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV